Mobile Health Intervention to Support Oral Chemotherapy Adherence in Adolescents and Young Adults With Leukemia
Launched by NORTHWESTERN UNIVERSITY · Apr 29, 2019
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is testing a new mobile health program designed to help young people with leukemia take their oral chemotherapy medicine regularly. It focuses on adolescents and young adults aged 14 to 29 who have been diagnosed with acute lymphoblastic leukemia (ALL) or lymphoblastic lymphoma and are currently in the maintenance phase of their treatment. This means they have already completed at least one cycle of treatment and have some time left in their therapy. To participate, they need to be taking a specific medication called 6-mercaptopurine, and they must be able to understand and communicate in English. Caregivers, such as parents or friends, can also be involved if they are nominated by the young person.
Participants in this trial will use a mobile app that provides support and reminders to help them stick to their medication schedule. The study aims to see if this mobile program is acceptable and helpful for young patients. This trial has not started recruiting participants yet, but it’s an important step toward improving treatment adherence for young people with leukemia, which can greatly impact their recovery and overall health.
Gender
ALL
Eligibility criteria
- AYA Inclusion Criteria:
- • Ages 14-29
- • Diagnosed with acute lymphoblastic leukemia (ALL) or lymphoma
- • In the maintenance phase, completed at least one cycle and has at least one month of maintenance therapy remaining.
- • Prescribed 6-mercaptopurine (6MP)
- • English language proficiency
- • For AYA \<18, must have informed consent from their caregiver.
- AYA Exclusion Criteria:
- • Cognitive impairments that would limit ability to complete measures, determined by the medical team
- • Absence of inclusion criteria above.
- Caregiver Inclusion Criteria:
- • Nominated by the AYA as a primary caregiver involved in cancer care (can be a parent, relative, partner, friend)
- • English language proficiency
- Caregiver Exclusion Criteria:
- • - Absence of inclusion criteria above.
About Northwestern University
Northwestern University is a prestigious academic institution renowned for its commitment to advancing medical research and improving patient care through innovative clinical trials. With a robust infrastructure that supports interdisciplinary collaboration, Northwestern leverages its expertise in various fields, including medicine, engineering, and social sciences, to drive groundbreaking studies. The university is dedicated to adhering to the highest ethical standards and regulatory compliance, ensuring that all clinical trials are conducted with the utmost integrity and focus on participant safety. Through its Clinical Trials Office, Northwestern aims to translate scientific discoveries into effective therapies, ultimately enhancing health outcomes and contributing to the broader medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Alexandra M Psihogios, Ph.D.
Principal Investigator
Northwestern University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials